Work

Phase II trial of bevacizumab in patients with surgery and radiation refractory progressive meningioma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.2055

Authors: Sean Aaron Grimm, Priya Kumthekar, Marc C. Chamberlain, David Schiff, Patrick Y. Wen, Fabio Massaiti Iwamoto, David A. Reardon, Benjamin Purow, Jeffrey J. Raizer

Institutions: Northwestern University, Seattle Cancer Care Alliance, University of Washington, Fred Hutch Cancer Center, University of Virginia Medical Center, University of Virginia, Dana-Farber Cancer Institute, Columbia University Irving Medical Center, Harvard University, Dana-Farber/Harvard Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Language: English

Topic: Meningioma and schwannoma management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2767061846

Cites:

Cited by: 21

Related to: 10